Search

Displaying results 5521 - 5530 of 10000 in total
  1. Drug

    Phenamazoline

    go.drugbank.com/drugs/DB19509
    Experimental

    Phenamazoline is a small molecule drug. The usage of the INN stem '-azoline' in the name indicates that Phenamazoline is a antihistaminic or local vasoconstrictor, antazoline derivative. … Phenamazoline has a monoisotopic molecular weight of 175.11 Da.

  2. Drug

    Afelimomab

    go.drugbank.com/drugs/DB04956
    Experimental

    Afelimomab (also known as Fab 2 or MAK 195F) is an anti-TNF-α monoclonal antibody. Administration of 195F reduces the concentration of interleukin-6 in patients with sepsis.

  3. Drug

    Itolizumab

    go.drugbank.com/drugs/DB16207
    Investigational

    Itolizumab is under investigation in clinical trial NCT04605926 (A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19).

  4. Drug

    Ropocamptide

    go.drugbank.com/drugs/DB16532
    Investigational

    Ropocamptide is a human cathelicidin that inhibits viral replication and while also playing a role in host defense against infection.

    Categories: Pore Forming Cytotoxic ProteinsSynonyms: LL-37, LL-37 antiviral peptide
  5. Drug

    Esmirtazapine

    go.drugbank.com/drugs/DB06678
    Investigational

    Merck has terminated its internal clinical development program for esmirtazapine as of March 2010.

    Synonyms: (S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine
  6. Drug

    CTCE-0214

    go.drugbank.com/drugs/DB05934
    Experimental

    CTCE-0214 is a stable peptide agonist of stromal cell-derived factor-1 (SDF-1), a key signaling molecule in the proliferation, homing, engraftment and expansion of hematopoietic stem cells and white blood

  7. Drug

    GSK-923295

    go.drugbank.com/drugs/DB06097
    Investigational

    GSK-923295 demonstrated a broad spectrum of activity against a range of human tumor xenografts grown in nude mice, including models of colon, breast, ovarian, lung and other tumors. … GSK-923295 is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E (CENP-E), and the third novel drug candidate to arise from Cytokinetics' broad strategic alliance with GlaxoSmithKline

  8. Drug

    Desoxycortone

    go.drugbank.com/drugs/DB15972
    Experimental

    Categories: Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain
  9. Drug

    Epicillin

    go.drugbank.com/drugs/DB13300
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  10. Drug

    AVN-944

    go.drugbank.com/drugs/DB05500
    Investigational

    It is being investigated for the treatment of patients with advanced hematologic malignancies. … AVN944 is a biotech drug that demonstrated a statistically meaningful impact on IMPDH and other proteins that are critical to activities in cancer cells, including nucleotide biosynthesis, energy and metabolism